Democratic Republic of the Congo

4 Vaccines Approved for Use in Democratic Republic of the Congo

RNA

Moderna

Spikevax

Approved in 86 countries
63 trials in 22 countries
Approval Source: actualite.cd
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
Approval Source: actualite.cd
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: actualite.cd
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
63 trials in 30 countries
Approval Source: aa.com.tr

2 in Clinical Trials in Democratic Republic of the Congo

Protein Subunit

Novavax

Nuvaxovid

Approved in 37 countries
16 trials in 12 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries